The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis
- 1 April 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 122 (4) , 545-551
- https://doi.org/10.1111/j.1365-2133.1990.tb14732.x
Abstract
A double-blind, randomized, cross-over study was carried out on the effect of a sedative and a non-sedative antihistamine on 25 adults with atopic dermatitis. Intensity of itch was recorded using a computerized method for self-assessment (Pain-Track) and using conventional visual analogue scales. The antipruritic effect of 3 days of treatment with the non-sedative H1 antagonist terfenadine (60 mg b.i.d.) and with the sedative antihistamine, clemastine (2 mg b.i.d.) did not differ from that found with the placebo. Our findings support the view that histamine is not of importance in the pathogenesis of itch in atopic dermatitis.This publication has 8 references indexed in Scilit:
- Treatment of itching in atopic eczema with antihistamines with a low sedative profile.BMJ, 1989
- SOME ASPECTS OF THE EXPERIMENTAL INDUCTION AND MEASUREMENT OF ITCH1989
- THE SENSITIVITY OF UREMIC AND NORMAL HUMAN-SKIN TO HISTAMINE1988
- Evaluation of a New Method of Assessing Pruritus and Antipruritic DrugsSkin Pharmacology and Physiology, 1988
- The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczemaClinical and Experimental Dermatology, 1986
- INTRACELLULAR CALCIUM RELEASE INDUCED BY HISTAMINE RELEASERS AND ITS INHIBITION BY SOME ANTIALLERGIC DRUGS1986
- Mechanism of action of antipruritic drugs.BMJ, 1983
- Diagnostic Features of Atopic DermatitisActa Dermato-Venereologica, 1980